Gentaur Donanemab – Anti-APP Antibody
Targets amyloid precursor protein (APP), used in Alzheimer’s disease research, amyloid clearance, and neurodegeneration assays.
Garantie satisfait ou remboursé de 30 jours
Livraison : 2-3 jours ouvrables